Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Maged Shenouda currently holds 800,000 shares of RELMADA THERAPEUTICS, INC. (RLMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maged Shenouda has been a net buyer of RLMD stock. They have purchased $1.5M and sold $1.3M worth of shares.
Maged Shenouda's most recent insider trade was on Dec 15, 2025, when they purchased 11,665 shares at $4.12 per share.
Maged Shenouda serves as Executive at RELMADA THERAPEUTICS, INC. (RLMD). They have executed 44 insider transactions totaling $2.7M over their tenure at the company.
Maged Shenouda holds the position of Executive at RELMADA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Maged Shenouda has shown a buying trading pattern, with $1.5M in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Maged Shenouda was on Jan 22, 2021, when they sold $1.3M worth of RLMD shares. This transaction involved 4,000 shares at $324.00 per share.
Maged Shenouda currently owns 800,000 shares of RELMADA THERAPEUTICS, INC. (RLMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Maged Shenouda's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Maged Shenouda has 44 Form 4 filings on record as an insider at RELMADA THERAPEUTICS, INC..
Set alerts for Maged Shenouda and 40,000+ other insiders.